Analysis-India regulatory reform could hasten homecoming of IPO-bound startups

India News

Analysis-India regulatory reform could hasten homecoming of IPO-bound startups
Startups
  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 92 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 63%

India's scrapping of a time-consuming compliance step will accelerate the pace at which Indian startups domiciled abroad shift back home to participate in...

BENGALURU - India 's scrapping of a time-consuming compliance step will accelerate the pace at which India n startups domiciled abroad shift back home to participate in the country's listing boom, according to bankers, lawyers and investors.

While Razorpay, Pine Labs and KreditBee are in advanced stages of completing the reverse flip, Zepto, Eruditus and InMobi are also trying to finish the merger process in the coming months in preparation for eventual IPOs, multiple sources said."India is a home market and a place where everybody knows and understands us. From a listing perspective, it makes sense to be in India," said Harshil Mathur, the co-founder and CEO of Razorpay.

"With the IPO market thriving, a reverse flip makes sense. Moreover, the streamlined merger process, designed to facilitate swift and efficient scheme approvals without court intervention, further supports this strategic move," said Mehul Shah, a partner at corporate law firm Khaitan & Co.Before the rule change, only a handful of companies such as Walmart-backed digital payments firm PhonePe and online investment platform Groww had engineered a reverse flip.

"Even without this regulation, last we saw eight to 10 new-age companies were on the path to reverse flip. So, this will encourage ," Gaurav Sood, head of equity capital markets at investment bank Avendus, said of the rule change.The homecoming of the IPO-bound startups is understandable given India's requirement that only local companies list on its exchanges and its ban on dual listings, along with a thin track record of such companies listing overseas.

"There is a strong appetite for tech stocks among Indian public investors, retail investors included," said Sandeep Patil, partner, and Asia head at venture capital firm QED Investors. CNN's Abby Phillip Says She Was 'So Happy' to See Hoda Kotb's Decision to Leave“ Today”: 'Courageous and Brave' CSUB men's basketball team is part of the first NIL program in Bakersfield

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooFinanceCA /  🏆 47. in CA

Startups

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Hyundai Aims to Raise Up to $3.3 Billion in Record India IPOHyundai Aims to Raise Up to $3.3 Billion in Record India IPO(Bloomberg) -- Hyundai Motor Co. is seeking to raise as much as $3.3 billion through an initial public offering of its Indian unit, kicking off the country’s...
Read more »

Hyundai prices $3 billion India IPO at 1,865-1,960 rupees per shareHyundai prices $3 billion India IPO at 1,865-1,960 rupees per shareHyundai Motor India has set a price range of 1,865 rupees ($22) to 1,960 rupees ($23) for its initial public offering (IPO) that opens next week for...
Read more »

Hyundai Motor to sell 142 million shares it holds in Hyundai Motor India for IPOHyundai Motor to sell 142 million shares it holds in Hyundai Motor India for IPOHyundai Motor said in a regulatory filing on Tuesday that it will sell 142 million shares it holds in Hyundai Motor India for the latter's initial public...
Read more »

Softbank-Backed Swiggy Said to Eye India IPO Filing This WeekSoftbank-Backed Swiggy Said to Eye India IPO Filing This Week(Bloomberg) -- Indian food-delivery platform Swiggy Ltd. is considering filing publicly for its domestic initial public offering as soon as this week, people...
Read more »

Zenas BioPharma raises $225 million in US IPOZenas BioPharma raises $225 million in US IPOZenas BioPharma, which is developing immunology-based therapies, said on Thursday it has raised $225 million in its U.S. initial public offering. The...
Read more »

Vancouver developer seeks to raise $82M for Metrotown project via IPOVancouver developer seeks to raise $82M for Metrotown project via IPOCapital sought for Metrotown project that is 77% pre-sold
Read more »



Render Time: 2025-02-19 18:22:18